ketoprofen has been researched along with Cat Diseases in 9 studies
Ketoprofen: An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.
ketoprofen : An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.
Cat Diseases: Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of the study was to evaluate the efficacy and tolerability of robenacoxib, a selective cyclooxygenase-2 inhibitor, for the treatment of acute pain and inflammation associated with musculoskeletal disorders in cats." | 9.16 | Comparison of oral robenacoxib and ketoprofen for the treatment of acute pain and inflammation associated with musculoskeletal disorders in cats: a randomised clinical trial. ( King, JN; Okumura, M; Sakakibara, N; Sano, T; Seewald, W, 2012) |
| "5mg/ml oral suspension, compared to ketoprofen tablets in cats suffering from painful acute locomotor disorders." | 9.15 | Clinical evaluation of meloxicam versus ketoprofen in cats suffering from painful acute locomotor disorders. ( Grant, D; Johnston, L; Letellier, IM; Morton, CM; Narbe, R, 2011) |
| "Robenacoxib tablets administered once daily had noninferior efficacy and tolerability, and superior palatability, compared with the active control drug, ketoprofen, for the treatment of signs of acute pain and inflammation associated with musculoskeletal disorders in cats." | 9.14 | Evaluation of orally administered robenacoxib versus ketoprofen for treatment of acute pain and inflammation associated with musculoskeletal disorders in cats. ( Alexander, DG; Giraudel, JM; Gruet, P; King, JN; Seewald, W, 2010) |
| "For robenacoxib, blood CL/F was 0." | 5.40 | Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation. ( Elliott, J; Hormazabal, V; King, JN; Lees, P; Pelligand, L; Toutain, PL, 2014) |
| "The objective of the study was to evaluate the efficacy and tolerability of robenacoxib, a selective cyclooxygenase-2 inhibitor, for the treatment of acute pain and inflammation associated with musculoskeletal disorders in cats." | 5.16 | Comparison of oral robenacoxib and ketoprofen for the treatment of acute pain and inflammation associated with musculoskeletal disorders in cats: a randomised clinical trial. ( King, JN; Okumura, M; Sakakibara, N; Sano, T; Seewald, W, 2012) |
| "5mg/ml oral suspension, compared to ketoprofen tablets in cats suffering from painful acute locomotor disorders." | 5.15 | Clinical evaluation of meloxicam versus ketoprofen in cats suffering from painful acute locomotor disorders. ( Grant, D; Johnston, L; Letellier, IM; Morton, CM; Narbe, R, 2011) |
| "Robenacoxib tablets administered once daily had noninferior efficacy and tolerability, and superior palatability, compared with the active control drug, ketoprofen, for the treatment of signs of acute pain and inflammation associated with musculoskeletal disorders in cats." | 5.14 | Evaluation of orally administered robenacoxib versus ketoprofen for treatment of acute pain and inflammation associated with musculoskeletal disorders in cats. ( Alexander, DG; Giraudel, JM; Gruet, P; King, JN; Seewald, W, 2010) |
| "Ketoprofen was a useful adjunct in the treatment of pyretic cats." | 2.68 | Use of ketoprofen as an antipyretic in cats. ( Aviad, AD; Glew, A; Keister, DM; Meo, NJ, 1996) |
| "For robenacoxib, blood CL/F was 0." | 1.40 | Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation. ( Elliott, J; Hormazabal, V; King, JN; Lees, P; Pelligand, L; Toutain, PL, 2014) |
| "Firocoxib is a potent COX-2 inhibitor and is the only selective COX-2 inhibitor described for use in cats to date." | 1.33 | In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia. ( Black, WC; Brideau, C; Cunningham, PK; Hickey, GJ; Hora, DF; McCann, ME; Rickes, EL; Zhang, D, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pelligand, L | 1 |
| King, JN | 3 |
| Hormazabal, V | 1 |
| Toutain, PL | 1 |
| Elliott, J | 1 |
| Lees, P | 1 |
| Giraudel, JM | 1 |
| Gruet, P | 1 |
| Alexander, DG | 1 |
| Seewald, W | 2 |
| Morton, CM | 1 |
| Grant, D | 1 |
| Johnston, L | 1 |
| Letellier, IM | 1 |
| Narbe, R | 1 |
| Sano, T | 1 |
| Sakakibara, N | 1 |
| Okumura, M | 1 |
| McCann, ME | 1 |
| Rickes, EL | 1 |
| Hora, DF | 1 |
| Cunningham, PK | 1 |
| Zhang, D | 1 |
| Brideau, C | 1 |
| Black, WC | 1 |
| Hickey, GJ | 1 |
| Taylor, PM | 1 |
| Robertson, SA | 1 |
| Dixon, MJ | 1 |
| Glew, A | 1 |
| Aviad, AD | 1 |
| Keister, DM | 1 |
| Meo, NJ | 1 |
| Slingsby, LS | 1 |
| Waterman-Pearson, AE | 1 |
| Lascelles, BD | 1 |
| Henderson, AJ | 1 |
| Hackett, IJ | 1 |
7 trials available for ketoprofen and Cat Diseases
| Article | Year |
|---|---|
Evaluation of orally administered robenacoxib versus ketoprofen for treatment of acute pain and inflammation associated with musculoskeletal disorders in cats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Appetite; Aspartate Aminotransferases; Behavior | 2010 |
Clinical evaluation of meloxicam versus ketoprofen in cats suffering from painful acute locomotor disorders.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cat Diseases; Cats; Female; | 2011 |
Comparison of oral robenacoxib and ketoprofen for the treatment of acute pain and inflammation associated with musculoskeletal disorders in cats: a randomised clinical trial.
Topics: Acute Pain; Administration, Oral; Animals; Cat Diseases; Cats; Cyclooxygenase 2 Inhibitors; Diphenyl | 2012 |
Evaluation of the use of thermal thresholds to investigate NSAID analgesia in a model of inflammatory pain in cats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cat Diseases; Cats; Cross-Over Studies; Female; Ho | 2007 |
Use of ketoprofen as an antipyretic in cats.
Topics: Amoxicillin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Cat Diseases; Cats; | 1996 |
Comparison of pethidine, buprenorphine and ketoprofen for postoperative analgesia after ovariohysterectomy in the cat.
Topics: Analgesia; Animals; Buprenorphine; Cat Diseases; Cats; Female; Hysterectomy; Ketoprofen; Meperidine; | 1998 |
Evaluation of the clinical efficacy of meloxicam in cats with painful locomotor disorders.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cat Diseases; Cats; Female; | 2001 |
2 other studies available for ketoprofen and Cat Diseases
| Article | Year |
|---|---|
Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cat Diseases; Cats; Diffusion Chamber | 2014 |
In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia.
Topics: 4-Butyrolactone; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cat Disease | 2005 |